Your browser doesn't support javascript.
loading
Drug repurposing against COVID-19: focus on anticancer agents.
Ciliberto, Gennaro; Mancini, Rita; Paggi, Marco G.
Affiliation
  • Ciliberto G; Scientific Director, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
  • Mancini R; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Paggi MG; Cellular Networks and Molecular Therapeutic Targets, Proteomics Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy. marco.paggi@ifo.gov.it.
J Exp Clin Cancer Res ; 39(1): 86, 2020 May 12.
Article in En | MEDLINE | ID: mdl-32398164
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Drug Repositioning / Antineoplastic Agents Limits: Humans Language: En Journal: J Exp Clin Cancer Res Year: 2020 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Drug Repositioning / Antineoplastic Agents Limits: Humans Language: En Journal: J Exp Clin Cancer Res Year: 2020 Document type: Article Affiliation country: Italy Country of publication: United kingdom